Out with Old Cancer Treatment Methods, Clay Siegall Determined to Show the Value of Targeted Treatment

Founder, President, CEO, and Chairman of the Board of Seattle Genetics, Dr. Clay Siegall is a man of many accomplishments. One may wonder how a Zoology student landed in the cancer research business, but as he tells Inspirery, the answer is a highly personal one. “A family member got sick and the treatment regimen was just brutal.” He shares that this family member nearly died from the chemotherapy treatment, not the cancer. When asked what makes Seattle Genetics successful, Seigall attributes it all to hard work, passion and inordinate amounts of focus.

Siegall obtained his Bachelor of Science degree in Zoology from the University of Maryland and his Ph. D in Genetics from George Washington University. His professional experience includes Bristol-Myers Squibb Pharmaceutical Research Institute and the National Institutes of Health, National Cancer Institute. He is the author of over 70 publications, holds 15 patents, and was recognized by his alma mater, the University of Maryland in 2013 as the Alumnus of the Year for Computer, Math and Natural Sciences. He also sits on the Board of Directors of Ultragenyx Pharmaceutical, Alder BioPharmaceuticals, and Washington Roundtable.

Dr. Clay Siegall founded Seattle Genetics in 1998. This global company is located in the Pacific Northwest of the U.S. focused on oncology biotechnology. Simply stated, they are in the business of transforming cancer treatment as we know it, through the creation of and making cancer treatment drugs available that are more effective and less detrimental on the patient. Their primary product is called Adcetris and treats Hodgkin lymphoma relapses as well as relapsed systemic anaplastic large cell lymphoma.

Clay is focused on innovating cancer treatment and is passionate about helping suffering from cancer, and he is good at what he does. He blogs regularly about the fight against cancer and admittedly shares about the stresses of starting a new company, but his persistence and passion saw Seattle Genetics through from challenging times to success. Admirably he doesn’t take all of the credit, publicly thanking the geneticists and sales members of his team for where his company is today.

 

Leave a Reply

Your email address will not be published. Required fields are marked *